![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Utilization of Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) for HIV Pre-Exposure Prophylaxis (PrEP) in the United States by Age, Gender and Race/Ethnicity (2014 - 2017)
|
|
|
Reported by Jules Levin
10th IAS Conference on HIV Science (IAS 2019), 21-24 July 2019, Mexico City, Mexico
C Nguyen, T Hawkins, J Anderson, S Bush, T Dinh, S McCallister, R Mera
Gilead Sciences, Inc., Foster City, CA, USA
![0724191](../images/072519/072519-6/0724191.gif)
![0724192](../images/072519/072519-6/0724192.gif)
![0724193](../images/072519/072519-6/0724193.gif)
![0724194](../images/072519/072519-6/0724194.gif)
![0724195](../images/072519/072519-6/0724195.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|